Thoroughbred Financial Services LLC Grows Position in Tilray Inc (NASDAQ:TLRY)

Thoroughbred Financial Services LLC boosted its holdings in Tilray Inc (NASDAQ:TLRY) by 546.5% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 66,247 shares of the company’s stock after acquiring an additional 56,000 shares during the period. Thoroughbred Financial Services LLC’s holdings in Tilray were worth $88,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of TLRY. Point72 Asset Management L.P. bought a new stake in shares of Tilray in the third quarter worth approximately $1,348,000. Atria Wealth Solutions Inc. grew its position in Tilray by 174.7% in the 4th quarter. Atria Wealth Solutions Inc. now owns 84,516 shares of the company’s stock worth $112,000 after purchasing an additional 53,751 shares during the period. Arizona State Retirement System grew its position in Tilray by 9.9% in the 4th quarter. Arizona State Retirement System now owns 261,233 shares of the company’s stock worth $347,000 after purchasing an additional 23,439 shares during the period. Swiss National Bank raised its stake in Tilray by 10.2% during the 4th quarter. Swiss National Bank now owns 1,776,638 shares of the company’s stock valued at $2,363,000 after buying an additional 164,600 shares during the last quarter. Finally, Barclays PLC lifted its holdings in shares of Tilray by 600.4% during the 3rd quarter. Barclays PLC now owns 204,144 shares of the company’s stock valued at $359,000 after buying an additional 174,997 shares during the period. Institutional investors own 9.35% of the company’s stock.

Tilray Stock Down 2.2 %

TLRY opened at $0.58 on Tuesday. The firm’s 50 day simple moving average is $0.79 and its two-hundred day simple moving average is $1.21. The company has a market capitalization of $543.18 million, a PE ratio of -1.93 and a beta of 1.88. Tilray Inc has a 1-year low of $0.54 and a 1-year high of $2.77. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10.

Tilray (NASDAQ:TLRY) last announced its earnings results on Friday, January 10th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.07). Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The company had revenue of $210.90 million during the quarter, compared to the consensus estimate of $216.34 million. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. As a group, equities analysts forecast that Tilray Inc will post -0.2 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group upped their price objective on Tilray from $2.00 to $3.00 and gave the company a “buy” rating in a research report on Monday, January 13th.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.